Cargando…

Clinical trials in cancer screening, prevention and early diagnosis (SPED): a systematic mapping review

BACKGROUND: Global annual cancer incidence is forecast to rise to 27.5 M by 2040, a 62% increase from 2018. For most cancers, prevention and early detection are the most effective ways of reducing mortality. This study maps trials in cancer screening, prevention, and early diagnosis (SPED) to identi...

Descripción completa

Detalles Bibliográficos
Autores principales:	O’Dowd, Emma L., Merriel, Samuel W. D., Cheng, Vinton W. T., Khan, Sam, Howells, Lynne M., Gopal, Dipesh P., Roundhill, Elizabeth A., Brennan, Paul M., Crosbie, Philip A. J., Neal, Richard D., Brown, Karen, Crosbie, Emma J., Baldwin, David R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476302/ https://www.ncbi.nlm.nih.gov/pubmed/37667231 http://dx.doi.org/10.1186/s12885-023-11300-8

Ejemplares similares

An eighteenth-century case history: Carlisle Spedding 1738
por: Beckett, J. V.
Publicado: (1982)

Silica nanoparticles with encapsulated DNA (SPED) to trace the spread of pathogens in healthcare
por: Ullrich, Cinzia, et al.
Publicado: (2022)

Lung nodules: sorting the wheat from the chaff
por: O’Dowd, Emma L, et al.
Publicado: (2023)

Fast but Not Furious. When Sped Up Bit Rate of Information Drives Rule Induction
por: Radulescu, Silvia, et al.
Publicado: (2021)

Silica nanoparticles with encapsulated DNA (SPED) – a novel surrogate tracer for microbial transmission in healthcare
por: Scotoni, Manuela, et al.
Publicado: (2020)

The implementation of salt reduction strategies should be sped up in Africa: a shout from Morocco
por: Noubiap, Jean Jacques
Publicado: (2020)

The Future of Lung Cancer Screening: Current Challenges and Research Priorities
por: Burzic, Amna, et al.
Publicado: (2022)

Use of systemic anti-cancer treatments in advanced stage non-small cell lung cancer during the SARS-CoV-2 pandemic in England and Wales: an analysis of the Rapid Cancer Registration Dataset
por: Morgan, Helen, et al.
Publicado: (2022)

New fissure-attached nodules in lung cancer screening: more practical implications from the NELSON study?
por: Morgan, Helen, et al.
Publicado: (2020)

Targeting lung cancer screening to individuals at greatest risk: the role of genetic factors
por: Lebrett, Mikey B, et al.
Publicado: (2021)

Impact of pre-treatment prognostic nutritional index and the haemoglobin, albumin, lymphocyte and platelet (HALP) score on endometrial cancer survival: A prospective database analysis
por: Njoku, Kelechi, et al.
Publicado: (2022)

Evaluating multi-cancer early detection tests: an argument for the outcome of recurrence-updated stage
por: Callister, Matthew E. J., et al.
Publicado: (2023)

Place of Death in Patients with Lung Cancer: A Retrospective Cohort Study from 2004-2013
por: O’Dowd, Emma L., et al.
Publicado: (2016)

Prevention Strategies in Endometrial Carcinoma
por: MacKintosh, Michelle L., et al.
Publicado: (2018)

Polygenic risk score opportunities for early detection and prevention strategies in endometrial cancer
por: O’Mara, Tracy A., et al.
Publicado: (2020)

The impact of COVID-19 on lung cancer diagnostics – a multicentre comparison of 2019/2020 data
por: Navani, Neal, et al.
Publicado: (2021)

Quantifying the impact of Covid-19 on lung cancer: an urgent need for restoration
por: O’Dowd, Emma, et al.
Publicado: (2021)

Lynch syndrome for the gynaecologist
por: Ryan, Neil AJ, et al.
Publicado: (2021)

Proteomic Biomarkers for the Detection of Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2019)

Impact of Type 2 Diabetes Mellitus on Endometrial Cancer Survival: A Prospective Database Analysis
por: Njoku, Kelechi, et al.
Publicado: (2022)

The impact of the Covid-19 pandemic on lung cancer incidence in England: an analysis of the 2019 and 2020 Rapid Cancer Registration Datasets
por: Gysling, Savannah, et al.
Publicado: (2022)

Pre-treatment inflammatory parameters predict survival from endometrial cancer: A prospective database analysis
por: Njoku, Kelechi, et al.
Publicado: (2022)

HE4 as a Biomarker for Endometrial Cancer
por: Behrouzi, Roya, et al.
Publicado: (2021)

Current and Emerging Prognostic Biomarkers in Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2022)

The development of the COVID-19 radiological learning system (CORALS ) to improve accurate management in the COVID-19 pandemic
por: Chen, Yan, et al.
Publicado: (2020)

Addressing transcranial electrical stimulation variability through prospective individualized dosing of electric field strength in 300 participants across two samples: the 2-SPED approach
por: Van Hoornweder, Sybren, et al.
Publicado: (2022)

What is the Definition of Cure in Non-small Cell Lung Cancer?
por: Morgan, Helen, et al.
Publicado: (2021)

Metabolomic Biomarkers for Detection, Prognosis and Identifying Recurrence in Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2020)

Human papillomavirus E7 induces p63 expression to modulate DNA damage response
por: Eldakhakhny, Sahar, et al.
Publicado: (2018)

Cervical screening: the evolving landscape
por: Davies-Oliveira, Jennifer C, et al.
Publicado: (2022)

Long-term risks of invasive cervical cancer following HPV infection: follow-up of two screening cohorts in Manchester
por: Gilham, Clare, et al.
Publicado: (2023)

Cost-Effectiveness of the Manchester Approach to Identifying Lynch Syndrome in Women with Endometrial Cancer
por: Snowsill, Tristan M., et al.
Publicado: (2020)

Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients
por: Merriel, Samuel W. D., et al.
Publicado: (2022)

The Impact of COVID-19 on Lung Cancer Incidence in England: Analysis of the National Lung Cancer Audit 2019 and 2020 Rapid Cancer Registration Datasets
por: Gysling, Savannah, et al.
Publicado: (2023)

Detecting ovarian cancer in primary care: can we do better?
por: Funston, Garth, et al.
Publicado: (2022)

How should performance in EBUS mediastinal staging in lung cancer be measured?
por: Evison, Matthew, et al.
Publicado: (2016)

Feasibility of Gynaecologist Led Lynch Syndrome Testing in Women with Endometrial Cancer
por: Ryan, Neil A. J., et al.
Publicado: (2020)

MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1
por: Flaum, Nicola, et al.
Publicado: (2023)

Serum CA125 and HE4 as Biomarkers for the Detection of Endometrial Cancer and Associated High-Risk Features
por: Barr, Chloe E., et al.
Publicado: (2022)

Urine CA125 and HE4 for the Detection of Ovarian Cancer in Symptomatic Women
por: Barr, Chloe E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c31nqi5pvuqvpd3oh5dp6i624v